2021 ICD-10-CM Code D07.0
Carcinoma in situ of endometrium
Valid for Submission
D07.0 is a billable diagnosis code used to specify a medical diagnosis of carcinoma in situ of endometrium. The code D07.0 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D07.0 might also be used to specify conditions or terms like carcinoma in situ of body of uterus, carcinoma in situ of endometrium, carcinoma in situ of isthmus of uterus, carcinoma in situ of myometrium, carcinoma in situ of placenta , carcinoma in situ of uterus, etc.
The code D07.0 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.
The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: Neoplasm, neoplastic corpus uteri ; Neoplasm, neoplastic corpus uteri isthmus ; Neoplasm, neoplastic endometrium (gland) (stroma) ; Neoplasm, neoplastic fetal membrane ; Neoplasm, neoplastic fundus uterus ; Neoplasm, neoplastic isthmus uteri ; Neoplasm, neoplastic myometrium ; etc
| ICD-10: | D07.0 |
| Short Description: | Carcinoma in situ of endometrium |
| Long Description: | Carcinoma in situ of endometrium |
Code Classification
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
- Diagnoses for females only - The Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, these edits apply to FEMALES only .
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Carcinoma in situ of body of uterus
- Carcinoma in situ of endometrium
- Carcinoma in situ of isthmus of uterus
- Carcinoma in situ of myometrium
- Carcinoma in situ of placenta
- Carcinoma in situ of uterus
- Neoplasm of isthmus of uterus
- Tis
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code D07.0 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2021.
- 736 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC - Relative Weight: 4.2582
- 737 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC - Relative Weight: 2.0582
- 738 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC - Relative Weight: 1.4766
- 739 - UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC - Relative Weight: 3.8217
- 740 - UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC - Relative Weight: 1.8
- 741 - UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC - Relative Weight: 1.2795
Convert D07.0 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code D07.0 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 233.2 - Ca in situ uterus NEC (Approximate Flag)
Table of Neoplasms
The code D07.0 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
| Neoplasm, neoplastic | Malignant Primary |
Malignant Secondary |
CaInSitu | Benign | Uncertain Behavior |
Unspecified Behavior |
|---|---|---|---|---|---|---|
| »Neoplasm, neoplastic »corpus »uteri | C54.9 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »corpus »uteri »isthmus | C54.0 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »endometrium (gland) (stroma) | C54.1 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »fetal membrane | C58 | C79.82 | D07.0 | D26.7 | D39.2 | D49.59 |
| »Neoplasm, neoplastic »fundus »uterus | C54.3 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »isthmus uteri | C54.0 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »myometrium | C54.2 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »placenta | C58 | C79.82 | D07.0 | D26.7 | D39.2 | D49.59 |
| »Neoplasm, neoplastic »stroma, endometrial | C54.1 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »uterus, uteri, uterine | C55 | C79.82 | D07.0 | D26.9 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »uterus, uteri, uterine »body | C54.9 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »uterus, uteri, uterine »cornu | C54.9 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »uterus, uteri, uterine »corpus | C54.9 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »uterus, uteri, uterine »endometrium | C54.1 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »uterus, uteri, uterine »fundus | C54.3 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »uterus, uteri, uterine »isthmus | C54.0 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »uterus, uteri, uterine »lower segment | C54.0 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
| »Neoplasm, neoplastic »uterus, uteri, uterine »myometrium | C54.2 | C79.82 | D07.0 | D26.1 | D39.0 | D49.59 |
Information for Patients
Uterine Cancer
Also called: Endometrial cancer
The uterus, or womb, is the place where a baby grows when a women is pregnant. There are different types of uterine cancer. The most common type starts in the endometrium, the lining of the uterus. This type is also called endometrial cancer.
The symptoms of uterine cancer include
- Abnormal vaginal bleeding or discharge
- Trouble urinating
- Pelvic pain
- Pain during intercourse
Uterine cancer usually happens after menopause. It is more common in women who have obesity. You also have a higher risk if you took estrogen-only hormone replacement therapy (menopausal hormone therapy) for many years.
Tests to find uterine cancer include a pelvic exam, imaging tests, and a biopsy. The most common treatment is a hysterectomy, which is surgery to remove the uterus. Sometimes the surgery also removes the ovaries and fallopian tubes. Other treatments include hormone therapy, radiation therapy, and chemotherapy. Some women get more than one type of treatment.
NIH: National Cancer Institute
- Choriocarcinoma (Medical Encyclopedia)
- Endometrial biopsy (Medical Encyclopedia)
- Endometrial cancer (Medical Encyclopedia)
- Uterine Cancer (Centers for Disease Control and Prevention)
[Learn More in MedlinePlus]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)